Mutant ATRX: uncovering a new therapeutic target for glioma

References

• Gibbons RJ, Picketts DJ, Villard L, et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 1995 Mar 24;80(6):837–845. PubMed PMID: 7697714; eng.
   PubMed Web of Science ®Google Scholar
• van den Bent MJ, Weller M, Wen PY, et al. A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics. Neuro-Oncology. 2017 May 01;19(5):614–624. PubMed PMID: 28339700; PubMed Central PMCID: PMCPmc5464438. eng.
   PubMed Web of Science ®Google Scholar
• Pekmezci M, Rice T, Molinaro AM, et al. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta Neuropathol. 2017 Jun;133(6):1001–1016. PubMed PMID: 28255664; PubMed Central PMCID: PMCPmc5432658. eng.
   PubMed Web of Science ®Google Scholar
• Koschmann C, Lowenstein PR, Castro MG. ATRX mutations and glioblastoma: impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability. Mol Cell Oncol. 2016 May;3(3):e1167158. . PubMed PMID: 27314101; PubMed Central PMCID: PMCPmc4909411. eng.
   PubMed Web of Science ®Google Scholar
• Amorim JP, Santos G, Vinagre J, et al. The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype. Genes (Basel). 2016 Sep 19;7(9). PubMed PMID: 27657132; PubMed Central PMCID: PMCPmc5042396. eng.
   PubMed Web of Science ®Google Scholar
• Lovejoy CA, Li W, Reisenweber S, et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. PLoS Genet. 2012;8(7):e1002772. PubMed PMID: 22829774; PubMed Central PMCID: PMC3400581. eng.
   PubMed Web of Science ®Google Scholar
• Heaphy CM, Subhawong AP, Hong SM, et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 2011 Oct;179(4):1608–1615. PubMed PMID: 21888887; PubMed Central PMCID: PMCPMC3181356.
   PubMed Web of Science ®Google Scholar
• Ramamoorthy M, Smith S. Loss of ATRX suppresses resolution of telomere cohesion to control recombination in ALT cancer cells. Cancer Cell. 2015 Sep 14;28(3):357–369. . PubMed PMID: 26373281; PubMed Central PMCID: PMCPmc4573400. eng.
   PubMed Web of Science ®Google Scholar
• Cai J, Chen J, Zhang W, et al. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors. Oncotarget. 2015 Jul 20;6(20):18105–18115. PubMed PMID: 25971279; PubMed Central PMCID: PMCPmc4627238. eng.
   PubMedGoogle Scholar
• Nandakumar P, Mansouri A, Das S. The role of ATRX in glioma biology. Front Oncol. 2017;7:236. PubMed PMID: 29034211; PubMed Central PMCID: PMCPmc5626857. eng.
   PubMed Web of Science ®Google Scholar
• Kannan K, Inagaki A, Silber J, et al. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget. 2012 Oct;3(10):1194–1203. PubMed PMID: 23104868; PubMed Central PMCID: PMCPmc3717947. eng.
   PubMed Web of Science ®Google Scholar
• Leeper HE, Caron AA, Decker PA, et al. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget. 2015 Oct 06;6(30):30295–30305. PubMed PMID: 26210286; PubMed Central PMCID: PMCPmc4745799. eng.
   PubMedGoogle Scholar
• Wiestler B, Capper D, Holland-Letz T, et al. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathol. 2013 Sep;126(3):443–451. PubMed PMID: 23904111; eng.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Killela PJ, Reitman ZJ, et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. 2012 Jul;3(7):709–722. PubMed PMID: 22869205; PubMed Central PMCID: PMCPmc3443254. eng.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Aoki K, Chiba K, et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015 May;47(5):458–468. PubMed PMID: 25848751; eng.
   PubMed Web of Science ®Google Scholar
• Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012 Jan 29;482(7384):226–231. PubMed PMID: 22286061; eng.
   PubMed Web of Science ®Google Scholar
• Koschmann C, Calinescu AA, Nunez FJ, et al. ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Sci Transl Med. 2016 Mar 02;8(328):328ra28. PubMed PMID: 26936505; PubMed Central PMCID: PMCPMC5381643.
   PubMed Web of Science ®Google Scholar
• Pathania M, De Jay N, Maestro N, et al. H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell. 2017 Nov 13;32(5):684–700.e9. PubMed PMID: 29107533; PubMed Central PMCID: PMCPmc5687892. eng.
   PubMed Web of Science ®Google Scholar
• Modrek AS, Golub D, Khan T, et al. Low-grade astrocytoma mutations in IDH1, P53, and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Reports. 2017 Oct 31;21(5):1267–1280. PubMed PMID: 29091765; PubMed Central PMCID: PMCPmc5687844. eng.
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Wada T, Fisher CA, et al. Mutations in the chromatin-associated protein ATRX. Hum Mutat. 2008 Jun;29(6):796–802. PubMed PMID: 18409179; eng.
   PubMed Web of Science ®Google Scholar
• Badens C, Martini N, Courrier S, et al. ATRX syndrome in a girl with a heterozygous mutation in the ATRX Zn finger domain and a totally skewed X-inactivation pattern. Am J Med Genet Part. 2006 Oct 15;140(20):2212–2215. PubMed PMID: 16955409; eng.
   PubMed Web of Science ®Google Scholar
• Garrick D, Samara V, McDowell TL, et al. A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain. Gene. 2004 Feb 04;326:23–34. PubMed PMID: 14729260; eng.
   PubMed Web of Science ®Google Scholar
• Iwase S, Xiang B, Ghosh S, et al. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat Struct Mol Biol. 2011 Jun 12;18(7):769–776. PubMed PMID: 21666679; PubMed Central PMCID: PMCPmc3130887. eng.
   PubMed Web of Science ®Google Scholar
• Xie S, Wang Z, Okano M, et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene. 1999 Aug 05;236(1):87–95. PubMed PMID: 10433969; eng.
   PubMed Web of Science ®Google Scholar
• Aapola U, Kawasaki K, Scott HS, et al. Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics. 2000 May 01;65(3):293–298. PubMed PMID: 10857753; eng.
   PubMed Web of Science ®Google Scholar
• Berube NG, Smeenk CA, Picketts DJ. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet. 2000 Mar 1;9(4):539–547. PubMed PMID: 10699177; eng.
   PubMed Web of Science ®Google Scholar
• Berube NG, Healy J, Medina CF, et al. Patient mutations alter ATRX targeting to PML nuclear bodies. EJHG. 2008 Feb;16(2):192–201. PubMed PMID: 17957225; eng.
   PubMed Web of Science ®Google Scholar
• Takagi M, Yagi H, Fukuzawa R, et al. Syndromic disorder of sex development due to a novel hemizygous mutation in the carboxyl-terminal domain of ATRX. Hum Genome Variation. 2017;4:17012. PubMed PMID: 28446958; PubMed Central PMCID: PMCPmc5389957. eng.
   PubMedGoogle Scholar
• Nguyen DT, Voon HPJ, Xella B, et al. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats. EMBO Reports. 2017 Jun;18(6):914–928. PubMed PMID: 28487353.
   PubMed Web of Science ®Google Scholar
• Badens C, Lacoste C, Philip N, et al. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet. 2006 Jul;70(1):57–62. PubMed PMID: 16813605; eng.
   PubMed Web of Science ®Google Scholar
• Garrick D, Sharpe JA, Arkell R, et al. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2006 Apr;2(4):e58. PubMed PMID: 16628246; PubMed Central PMCID: PMCPmc1440874. eng.
   PubMed Web of Science ®Google Scholar
• Berube NG, Mangelsdorf M, Jagla M, et al. The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest. 2005 Feb;115(2):258–267. PubMed PMID: 15668733; PubMed Central PMCID: PMCPmc544602. eng.
   PubMed Web of Science ®Google Scholar
• Huh MS, Price O’Dea T, Ouazia D, et al. Compromised genomic integrity impedes muscle growth after Atrx inactivation. J Clin Invest. 2012 Dec;122(12):4412–4423. PubMed PMID: 23114596; PubMed Central PMCID: PMCPmc3533543. eng.
   PubMed Web of Science ®Google Scholar
• Conte D, Huh M, Goodall E, et al. Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways. PloS One. 2012;7(12):e52167. PubMed PMID: 23284920; PubMed Central PMCID: PMCPmc3524112. eng.
   PubMed Web of Science ®Google Scholar
• Bagheri-Fam S, Argentaro A, Svingen T, et al. Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Hum Mol Genet. 2011 Jun 01;20(11):2213–2224. PubMed PMID: 21427128; eng.
   PubMed Web of Science ®Google Scholar
• Solomon LA, Russell BA, Watson LA, et al. Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly. Hum Mol Genet. 2013 Dec 15;22(24):5015–5025. PubMed PMID: 23892236; eng.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, NY). 2011 Mar 4;331(6021):1199–1203. PubMed PMID: 21252315; PubMed Central PMCID: PMCPmc3144496. eng.
   Google Scholar
• Cheung NK, Zhang J, Lu C, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA. 2012 Mar 14;307(10):1062–1071. PubMed PMID: 22416102; PubMed Central PMCID: PMCPmc3527076. eng.
   PubMed Web of Science ®Google Scholar
• Pinto EM, Chen X, Easton J, et al. Genomic landscape of paediatric adrenocortical tumours. Nat Commun. 2015 Mar 6;6:6302. . PubMed PMID: 25743702.
   Google Scholar
• Assie G, Letouze E, Fassnacht M, et al. Integrated genomic characterization of adrenocortical carcinoma. Nat Genet. 2014 Jun;46(6):607–612. PubMed PMID: 24747642.
   Google Scholar
• Chen X, Bahrami A, Pappo A, et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Reports. 2014 Apr 10;7(1):104–112. PubMed PMID: 24703847; PubMed Central PMCID: PMCPmc4096827. eng.
   PubMed Web of Science ®Google Scholar
• Yang X, Khosravi-Far R, Chang HY, et al. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 1997 Jun 27;89(7):1067–1076. PubMed PMID: 9215629; PubMed Central PMCID: PMCPmc2989411. eng.
   PubMed Web of Science ®Google Scholar
• Xue Y, Gibbons R, Yan Z, et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10635–10640. PubMed PMID: 12953102; PubMed Central PMCID: PMCPmc196856. eng.
   PubMed Web of Science ®Google Scholar
• Tang J, Wu S, Liu H, et al. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J Biol Chem. 2004 May 07;279(19):20369–20377. PubMed PMID: 14990586; eng.
   PubMed Web of Science ®Google Scholar
• Goldberg AD, Banaszynski LA, Noh KM, et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell. 2010 Mar 05;140(5):678–691. PubMed PMID: 20211137; PubMed Central PMCID: PMCPmc2885838. eng.
   PubMed Web of Science ®Google Scholar
• Lewis PW, Elsaesser SJ, Noh KM, et al. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14075–14080. PubMed PMID: 20651253; PubMed Central PMCID: PMCPmc2922592. eng.
   PubMed Web of Science ®Google Scholar
• Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Molecular Cell. 2002 Jun;9(6):1191–1200. PubMed PMID: 12086617; eng.
   PubMed Web of Science ®Google Scholar
• Dyer MA, Qadeer ZA, Valle-Garcia D, et al. ATRX and DAXX: mechanisms and mutations. Cold Spring Harb Perspect Med. 2017 Mar 1;7(3). PubMed PMID: 28062559; eng.
   PubMed Web of Science ®Google Scholar
• Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006–1016. . PubMed PMID: 17928811; eng.
   PubMed Web of Science ®Google Scholar
• Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays. 2004 Sep;26(9):963–977. . PubMed PMID: 15351967; eng.
   PubMed Web of Science ®Google Scholar
• de Stanchina E, Querido E, Narita M, et al. PML is a direct p53 target that modulates p53 effector functions. Molecular Cell. 2004 Feb 27;13(4):523–535. PubMed PMID: 14992722; eng.
   PubMed Web of Science ®Google Scholar
• Wang J, Shiels C, Sasieni P, et al. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol. 2004 Feb 16;164(4):515–526. PubMed PMID: 14970191; PubMed Central PMCID: PMCPmc2171989. eng.
   PubMed Web of Science ®Google Scholar
• Ishov AM, Sotnikov AG, Negorev D, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999 Oct 18;147(2):221–234. PubMed PMID: 10525530; PubMed Central PMCID: PMCPmc2174231. eng.
   PubMed Web of Science ®Google Scholar
• Delbarre E, Ivanauskiene K, Kuntziger T, et al. DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin. Genome Res. 2013 Mar;23(3):440–451. PubMed PMID: 23222847; PubMed Central PMCID: PMCPmc3589533. eng.
   PubMed Web of Science ®Google Scholar
• Delbarre E, Ivanauskiene K, Spirkoski J, et al. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX. Genome Res. 2017 Jun;27(6):913–921. PubMed PMID: 28341773; PubMed Central PMCID: PMCPmc5453325. eng.
   PubMed Web of Science ®Google Scholar
• Sarma K, Cifuentes-Rojas C, Ergun A, et al. ATRX directs binding of PRC2 to Xist RNA and polycomb targets. Cell. 2014 Nov 06;159(4):869–883. PubMed PMID: 25417162; PubMed Central PMCID: PMCPmc4379047. eng.
   PubMed Web of Science ®Google Scholar
• Rhodes D, Lipps HJ. G-quadruplexes and their regulatory roles in biology. Nucleic Acids Res. 2015 Oct 15;43(18):8627–8637. PubMed PMID: 26350216; PubMed Central PMCID: PMCPmc4605312. eng.
   PubMed Web of Science ®Google Scholar
• Law MJ, Lower KM, Voon HP, et al. ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell. 2010 Oct 29;143(3):367–378. PubMed PMID: 21029860; eng.
   PubMed Web of Science ®Google Scholar
• Ratnakumar K, Duarte LF, LeRoy G, et al. ATRX-mediated chromatin association of histone variant macroH2A1 regulates alpha-globin expression. Genes Dev. 2012 Mar 01;26(5):433–438. PubMed PMID: 22391447; PubMed Central PMCID: PMCPmc3305981. eng.
   PubMed Web of Science ®Google Scholar
• Clynes D, Jelinska C, Xella B, et al. ATRX dysfunction induces replication defects in primary mouse cells. PloS One. 2014;9(3):e92915. PubMed PMID: 24651726; PubMed Central PMCID: PMCPmc3961441. eng.
   PubMed Web of Science ®Google Scholar
• Huh MS, Ivanochko D, Hashem LE, et al. Stalled replication forks within heterochromatin require ATRX for protection. Cell Death Dis. 2016 May 12;7:e2220.
   PubMed Web of Science ®Google Scholar
• Elsasser SJ, Noh KM, Diaz N, et al. Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells. Nature. 2015 Jun 11;522(7555):240–244. PubMed PMID: 25938714; PubMed Central PMCID: PMCPmc4509593. eng.
   PubMed Web of Science ®Google Scholar
• Sadic D, Schmidt K, Groh S, et al. Atrx promotes heterochromatin formation at retrotransposons. EMBO Reports. 2015 Jul;16(7):836–850. PubMed PMID: 26012739; PubMed Central PMCID: PMCPmc4515123. eng.
   PubMed Web of Science ®Google Scholar
• He Q, Kim H, Huang R, et al. The Daxx/Atrx complex protects tandem repetitive elements during DNA hypomethylation by promoting H3K9 trimethylation. Cell Stem Cell. 2015 Sep 03;17(3):273–286. PubMed PMID: 26340527; PubMed Central PMCID: PMCPmc4571182. eng.
   PubMed Web of Science ®Google Scholar
• Hoelper D, Huang H. Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX. Nat Commun. 2017 Oct 30;8(1):1193. 10.1038/s41467-017-01206-y. PubMed PMID: 29084956.
   Google Scholar
• Dhwani Tadepally H, Aubry M. Evolution of C2H2 Zinc-finger gene families in mammals. eLS. 2010. DOI:10.1002/9780470015902.a0021738
   Google Scholar
• Valle-Garcia D, Qadeer ZA, McHugh DS, et al. ATRX binds to atypical chromatin domains at the 3ʹ exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics. 2016 Jun 02;11(6):398–414. PubMed PMID: 27029610; PubMed Central PMCID: PMCPmc4939920. eng.
   PubMed Web of Science ®Google Scholar
• Dupont C, Gribnau J. Different flavors of X-chromosome inactivation in mammals. Curr Opin Cell Biol. 2013 Jun;25(3):314–321. . PubMed PMID: 23578369; eng.
   PubMed Web of Science ®Google Scholar
• Lee JT. Epigenetic regulation by long noncoding RNAs. Science (New York, NY). 2012 Dec 14;338(6113):1435–1439. . PubMed PMID: 23239728; eng.
   Google Scholar
• Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell. 2013 Mar 14;152(6):1308–1323. . PubMed PMID: 23498939; eng.
   PubMed Web of Science ®Google Scholar
• Starmer J, Magnuson T. A new model for random X chromosome inactivation. Development. 2009 Jan;136(1):1–10. . PubMed PMID: 19036804; PubMed Central PMCID: PMCPmc2630377. eng.
   PubMed Web of Science ®Google Scholar
• Wutz A. Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet. 2011 Jul 18;12(8):542–553. . PubMed PMID: 21765457; eng.
   PubMed Web of Science ®Google Scholar
• Muller J, Verrijzer P. Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev. 2009 Apr;19(2):150–158. . PubMed PMID: 19345089; eng.
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingston RE. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Molecular Cell. 2013 Mar 07;49(5):808–824. . PubMed PMID: 23473600; PubMed Central PMCID: PMCPmc3628831. eng.
   PubMed Web of Science ®Google Scholar
• Kinde B, Gabel HW, Gilbert CS, et al. Reading the unique DNA methylation landscape of the brain: non-CpG methylation, hydroxymethylation, and MeCP2. Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6800–6806. PubMed PMID: 25739960; PubMed Central PMCID: PMCPmc4460470. eng.
   PubMed Web of Science ®Google Scholar
• Nacarelli T, Liu P, Zhang R. Epigenetic basis of cellular senescence and its implications in aging. Genes. 2017 Nov 24;8(12). PubMed PMID: 29186801; PubMed Central PMCID: PMCPmc5748661. eng. DOI: 10.3390/genes8120343.
   PubMed Web of Science ®Google Scholar
• Kovatcheva M, Liao W. ATRX is a regulator of therapy induced senescence in human cells. 2017 Aug 30;8(1):386. Nat Commun.  PubMed PMID: 28855512.
   Google Scholar
• Kovatcheva M, Klein ME, Tap WD, et al. Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors. Mol Cell Oncol . 2018;5(1):e1384882. PubMed PMID: 29404388; PubMed Central PMCID: PMCPmc5791849. eng. .
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016 Jun;131(6):803–820. PubMed PMID: 27157931; eng.
   PubMed Web of Science ®Google Scholar
• Olar A, Sulman EP. Molecular markers in low-grade glioma-toward tumor reclassification. Semin Radiat Oncol. 2015 Jul;25(3):155–163. . PubMed PMID: 26050585; PubMed Central PMCID: PMCPmc4500036. eng.
   PubMed Web of Science ®Google Scholar
• Network CGAR. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061–1068. PubMed PMID: 18772890; PubMed Central PMCID: PMCPmc2671642. eng.
   PubMed Web of Science ®Google Scholar
• Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462–477. PubMed PMID: 24120142; PubMed Central PMCID: PMCPmc3910500. eng.
   PubMed Web of Science ®Google Scholar
• Sturm D, Witt H, Hovestadt V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012 Oct 16;22(4):425–437. PubMed PMID: 23079654; eng.
   PubMed Web of Science ®Google Scholar
• Sturm D, Bender S, Jones DT, et al. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer. 2014 Feb;14(2):92–107. PubMed PMID: 24457416; PubMed Central PMCID: PMCPmc4003223. eng.
   PubMed Web of Science ®Google Scholar
• Masui K, Mischel PS, Reifenberger G. Molecular classification of gliomas. Handb Clin Neurol. 2016;134:97–120. PubMed PMID: 26948350; eng.
   PubMedGoogle Scholar
• Liu XY, Gerges N, Korshunov A, et al. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol. 2012 Nov;124(5):615–625. PubMed PMID: 22886134; eng.
   PubMed Web of Science ®Google Scholar
• Heaphy CM, De Wilde RF, Jiao Y, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science (New York, NY). 2011 Jul 22;333(6041):425. PubMed PMID: 21719641; PubMed Central PMCID: PMCPmc3174141. eng.
   Google Scholar
• Ebrahimi A, Skardelly M, Bonzheim I, et al. ATRX immunostaining predicts IDH and H3F3A status in gliomas. Acta Neuropathol Commun. 2016 Jun 16;4(1):60. 10.1186/s40478-016-0331-6. PubMed PMID: 27311324; PubMed Central PMCID: PMCPmc4910252. eng.
   PubMed Web of Science ®Google Scholar
• Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015 Jun 25;372(26):2499–2508. PubMed PMID: 26061753; PubMed Central PMCID: PMCPmc4489704. eng.
   PubMed Web of Science ®Google Scholar
• Fontebasso AM, Gayden T, Nikbakht H, et al. Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathol. 2014 Nov;128(5):615–627. PubMed PMID: 25077668; PubMed Central PMCID: PMCPmc4201756. eng.
   PubMed Web of Science ®Google Scholar
• Pathak P, Jha P, Purkait S, et al. Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM. J Neurooncol. 2015 Feb;121(3):489–497. PubMed PMID: 25479829; eng.
   PubMed Web of Science ®Google Scholar
• Wu G, Diaz AK, Paugh BS, et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet. 2014 May;46(5):444–450. PubMed PMID: 24705251; PubMed Central PMCID: PMCPmc4056452. eng.
   PubMed Web of Science ®Google Scholar
• Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012 Jan 29;44(3):251–253. PubMed PMID: 22286216; PubMed Central PMCID: PMCPmc3288377. eng.
   PubMed Web of Science ®Google Scholar
• Jones C, Baker SJ. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer. 2014 Oct;14(10). PubMed PMID: 25230881; PubMed Central PMCID: PMCPmc4747023. eng. DOI:10.1038/nrc3811
   Web of Science ®Google Scholar
• Jansen MH, Veldhuijzen Van Zanten SE, Sanchez Aliaga E, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro-Oncology. 2015 Jan;17(1):160–166. PubMed PMID: 24903904; PubMed Central PMCID: PMCPmc4483042. eng.
   PubMed Web of Science ®Google Scholar
• Khuong-Quang DA, Buczkowicz P, Rakopoulos P, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012 Sep;124(3):439–447. PubMed PMID: 22661320; PubMed Central PMCID: PMCPmc3422615. eng.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Wood MD, Tihan T, et al. Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol. 2016 Sep;26(5):569–580. PubMed PMID: 26517431; eng.
   PubMed Web of Science ®Google Scholar
• Cohen KJ, Jabado N, Grill J. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro-Oncology. 2017 Aug 01;19(8):1025–1034. . PubMed PMID: 28371920; PubMed Central PMCID: PMCPmc5570259. eng.
   PubMed Web of Science ®Google Scholar
• Taylor KR, Mackay A, Truffaux N, et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet. 2014 May;46(5):457–461. PubMed PMID: 24705252; PubMed Central PMCID: PMCPmc4018681. eng.
   PubMed Web of Science ®Google Scholar
• Danussi C, Bose P, Parthasarathy PT, et al. Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nat Commun. 2018 Mar 13;9(1):1057. . PubMed PMID: 29535300.
   Google Scholar
• Cheung AL, Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci. 2008 Jan;01(13):2075–2090. PubMed PMID: 17981693.
   Google Scholar
• Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability–an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010 Mar;11(3):220–228. . PubMed PMID: 20177397.
   PubMed Web of Science ®Google Scholar
• Shiras A, Chettiar ST, Shepal V, et al. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007 Jun;25(6):1478–1489. PubMed PMID: 17332509.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006 Dec 07;444(7120):756–760. PubMed PMID: 17051156.
   PubMed Web of Science ®Google Scholar
• Perez-Garcia A, Carrion-Navarro J, Bosch-Fortea M, et al. Genomic instability of surgical sample and cancer-initiating cell lines from human glioblastoma. Front Biosci (Landmark Ed). 2012 Jan;01(17):1469–1479. PubMed PMID: 22201815.
   Google Scholar
• Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol. 2006 Dec;18(6):658–667. . PubMed PMID: 17046232.
   PubMed Web of Science ®Google Scholar
• Godek KM, Venere M, Wu Q, et al. Chromosomal instability affects the tumorigenicity of glioblastoma tumor-initiating cells. Cancer Discov. 2016 May;6(5):532–545. PubMed PMID: 27001151; PubMed Central PMCID: PMCPMC4854766.
   PubMed Web of Science ®Google Scholar
• Ritchie K, Seah C, Moulin J, et al. Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol. 2008 Jan 28;180(2):315–324. PubMed PMID: 18227278; PubMed Central PMCID: PMCPMC2213576.
   PubMed Web of Science ®Google Scholar
• Wong LH, McGhie JD, Sim M, et al. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res. 2010 Mar;20(3):351–360. PubMed PMID: 20110566; PubMed Central PMCID: PMCPMC2840985.
   PubMed Web of Science ®Google Scholar
• Baumann C, Viveiros MM, De La Fuente R. Loss of maternal ATRX results in centromere instability and aneuploidy in the mammalian oocyte and pre-implantation embryo. PLoS Genet. 2010 Sep 23;6(9):e1001137. . PubMed PMID: 20885787; PubMed Central PMCID: PMCPMC2944790.
   PubMed Web of Science ®Google Scholar
• Watson LA, Goldberg H, Berube NG. Emerging roles of ATRX in cancer. Epigenomics. 2015;7(8):1365–1378. PubMed PMID: 26646632.
   PubMed Web of Science ®Google Scholar
• Watson LA, Solomon LA, Li JR, et al. Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. J Clin Invest. 2013 May;123(5):2049–2063. PubMed PMID: 23563309; PubMed Central PMCID: PMCPMC3635723.
   PubMed Web of Science ®Google Scholar
• De La Fuente R, Baumann C, Viveiros MM. Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease. Reproduction. 2011 Aug;142(2):221–234. . PubMed PMID: 21653732; PubMed Central PMCID: PMCPMC3253860.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009 Oct 22;461(7267):1071–1078. . PubMed PMID: 19847258; PubMed Central PMCID: PMCPMC2906700.
   PubMed Web of Science ®Google Scholar
• Giglia-Mari G, Zotter A, Vermeulen W. DNA damage response. Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a000745. . PubMed PMID: 20980439; PubMed Central PMCID: PMCPMC3003462.
   PubMed Web of Science ®Google Scholar
• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010 Oct 22;40(2):179–204. . PubMed PMID: 20965415; PubMed Central PMCID: PMCPMC2988877.
   PubMed Web of Science ®Google Scholar
• Leung JW, Ghosal G, Wang W, et al. Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress. J Biol Chem. 2013 Mar 01;288(9):6342–6350. PubMed PMID: 23329831; PubMed Central PMCID: PMCPmc3585069. eng.
   PubMed Web of Science ®Google Scholar
• Clynes D, Jelinska C, Xella B, et al. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX. Nat Commun. 2015 Jul 6;6:7538. PubMed PMID: 26143912; PubMed Central PMCID: PMCPmc4501375. eng.
   PubMed Web of Science ®Google Scholar
• Conomos D, Reddel RR. NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nat Struct Mol Biol. 2014 Sep;21(9):760–770. . PubMed PMID: 25150861.
   Google Scholar
• Kato K, Omura H, Ishitani R, et al. Cyclic GMP-AMP as an endogenous second messenger in innate immune signaling by cytosolic DNA. Annu Rev Biochem. 2017 Jun 20;86:541–566. PubMed PMID: 28399655; eng.
   PubMed Web of Science ®Google Scholar
• Chen YA, Shen YL, Hsia HY, et al. Extrachromosomal telomere repeat DNA is linked to ALT development via cGAS-STING DNA sensing pathway. Nat Struct Mol Biol. 2017 Dec;24(12):1124–1131. PubMed PMID: 29106411.
   Google Scholar
• Ahuja N, Sharma AR, Baylin SB. Epigenetic therapeutics: a new weapon in the war against cancer. Annu Rev Med. 2016;67:73–89. PubMed PMID: 26768237; PubMed Central PMCID: PMCPmc4937439. Eng.
   PubMed Web of Science ®Google Scholar
• McLuckie KI, Di Antonio M, Zecchini H, et al. G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells. J Am Chem Soc. 2013 Jul 3;135(26):9640–9643. PubMed PMID: 23782415; PubMed Central PMCID: PMCPmc3964824. eng.
   PubMed Web of Science ®Google Scholar
• Porru M, Pompili L, Caruso C, et al. Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities. J Exp Clin Cancer Res. 2018 Mar 13;37(1):57. PubMed PMID: 29534749.
   Google Scholar
• Bidzinska J, Cimino-Reale G, Zaffaroni N, et al. G-quadruplex structures in the human genome as novel therapeutic targets. Molecules. 2013 Oct 8;18(10):12368–12395. PubMed PMID: 24108400; eng.
   PubMed Web of Science ®Google Scholar
• Zimmer J, Tacconi EMC, Folio C, et al. Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds. Molecular Cell. 2016 Feb 4;61(3):449–460. PubMed PMID: 26748828; PubMed Central PMCID: PMCPmc4747901. eng.
   PubMed Web of Science ®Google Scholar
• Dilley RL, Greenberg RA. ALTernative telomere maintenance and cancer. Trends Cancer. 2015 Oct 1;1(2):145–156. . PubMed PMID: 26645051; PubMed Central PMCID: PMCPmc4669901. eng.
   PubMed Web of Science ®Google Scholar
• Jager K, Walter M. Therapeutic targeting of telomerase. Genes. 2016 Jul 21;7(7). PubMed PMID: 27455328; PubMed Central PMCID: PMCPmc4962009. eng. DOI: 10.3390/genes7070039.
   PubMed Web of Science ®Google Scholar
• Flynn RL, Cox KE, Jeitany M, et al. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science (New York, NY). 2015 Jan 16;347(6219):273–277. PubMed PMID: 25593184; PubMed Central PMCID: PMCPmc4358324. eng.
   Google Scholar
• Clynes D, Higgs DR, Gibbons RJ. The chromatin remodeller ATRX: a repeat offender in human disease. Trends Biochem Sci. 2013 Sep;38(9):461–466. PubMed PMID: 23916100; eng.
   PubMed Web of Science ®Google Scholar